0
杂质现货
0
+
可供中间体
0
+
可供原料药
0
+
可联合审报的产品
洛索洛芬钠中间体
克唑替尼中间体
枸橼酸西地那非中间体
托法替尼中间体
依帕列净中间体
达格列净中间体
洛索洛芬钠中间体
| 洛索洛芬酸 | 68767-14-6 |
| Loxoprofen | |
| 对溴甲基异苯丙酸 | 111128-12-2 |
| 2-(4-Bromomethyl)phenylpropionic acid | |
| 甲氧羰基环戊酮 | 10472-24-9 |
| Methyl 2-cyclopentanonecarboxylate |
克唑替尼中间体
| 4-[4-[6-氨基-5-[[(R)-1-(2,6-二氯-3-氟苯基)乙基]氧基]吡啶-3-基]吡唑-1-基]哌啶-1-羧酸叔丁酯， 4-[4-[6-Amino-5-[[(R)-1-(2,6-dichloro-3-fluorophenyl)ethyl]oxy]pyridin-3-yl]pyrazol-1-yl]piperidine-1-carboxylic acid tert-butyl ester |
877399-51-4 |
| (S)-1-(2,6-二氯-3-氟苯基)乙醇， (S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol |
877397-65-4 |
| [5-溴-3-[(1R)-(2,6-二氯-3-氟苯基)乙氧基]吡啶-2-基]胺， [5-Bromo-3-[(1R)-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-yl]amine |
877399-00-3 |
| 4-[4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-吡唑-1-基]哌啶-1-甲酸叔丁酯， tert-Butyl 4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidine-1-carboxylate |
877399-74-1 |
枸橼酸西地那非中间体
| 4-氨基-1-甲基-3-丙基-1H-吡唑-5-甲酰胺盐酸盐 | 1688656-88-3 |
| 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide hydrochloride | |
| 4-(2-乙氧基-5-((4-甲基哌嗪-1-基)磺酰基)苯甲酰胺基)-1-甲基-3-丙基-1H-吡唑-5-甲酰胺 | 200575-15-1 |
| 4-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzamido}-1-methyl-3-propyl-1H-pyrazole-5-carboxamide | |
| 西地那非 | 139755-83-2 |
| 5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one |
托法替尼中间体
| 4-氯-7-甲苯磺酰基-7H-吡咯[2,3-D]嘧啶， 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine |
479633-63-1 |
| 4-氯吡咯并[2,3-d]嘧啶， 4-Chloropyrrolo[2,3-d]pyrimidine |
3680-69-1 |
| 4-羟基吡咯并[2,3-d]嘧啶， Pyrrolo[2,3-d]pyrimidin-4-ol |
3680-71-5 |
| (3R,4R)-N,4-二甲基-1-(苯基甲基)-3-哌啶胺盐酸盐， (3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride |
1062580-52-2 |
依帕列净中间体
| (1S)-1,5-脱水-1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-D-山梨糖醇四乙酸酯, Peracetyl Empagliflozin |
915095-99-7 |
| 依帕列净对接物/甲基 1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-alpha-D-吡喃葡萄糖苷, 1-Methoxy Empagliflozin |
1279691-36-9 |
| (3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氢呋喃, (3S)-3-4-(5-Bromo-2-chlorophenyl)methylphenoxytetrahydrofuran |
915095-89-5 |
| 依帕列净碘代起始物料 /(3S)-3-[4-[(2-氯-5-碘苯基)甲基]苯氧基]四氢呋喃, (3S)-3-{4-[(2-chloro-5-iodophenyl)methyl]phenoxy}oxolane |
915095-94-2 |
| (2-氯-5-碘苯基)[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲酮, (2-Chloro-5-iodophenyl)4-(3S)-tetrahydro-3-furanyloxyphenylmethanone |
915095-87-3 |
| (S)-(+)-3-羟基四氢呋喃, (S)-Tetrahydrofuran-3-ol |
86087-23-2 |
| 2,3,4,6-四-O-三甲基硅基-D-葡萄糖酸内酯/硅醚物, (3R,4S,5R,6R)-3,4,5-tris[(trimethylsilyl)oxy]-6-{[(trimethylsilyl)oxy]methyl}oxan-2-one |
32384-65-9 |
| 2-氯-5-溴苯甲酸, 5-bromo-2-chloro-benzoic acid |
21739-92-4 |
达格列净中间体
| (1S)-1,5-脱水-1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-D-葡萄糖醇, Dapagliflozin |
461432-26-8 |
| (1S)-1,5-脱水-1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-D-山梨醇四乙酸酯, Dapagliflozin Tetraacetate |
461432-25-7 |
| 甲基 1-C-[4-氯-3-[(4-乙氧基苯基)甲基]苯基]-alpha-D-吡喃葡萄糖苷, 1a-Methyl Dapagliflozin |
714269-57-5 |
| 5-溴-2-氯-4′-乙氧基二苯甲烷, 4-bromo-1-chloro-2-[(4-ethoxyphenyl)methyl]benzene |
461432-23-5 |
| 1-氯-2-(4-乙氧基苄基)-4-碘代苯/达格列净碘代起始物料,1-chloro-2-[(4-ethoxyphenyl)methyl]-4-iodobenzene | 1103738-29-9 |
联系我们
如您对我们的产品或服务感兴趣请联系我们！
联系电话：021-50780965/13391093349
业务邮箱：sales@spbtcl.com
业务QQ：3127819903
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。